Book Value per Share: SXT Pharmaceuticals (SXTC)

Graphic logo of China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals (SXTC) is currently in a stagnation phase as its traditional medicine portfolio loses relevance. The business relies on the supply of generics to Chinese clinics and pharmacies, targeting the Asian healthcare market. The current indicator is 250416.74. The security price action shown below reflects volatility driven by stringent product quality oversight, low asset liquidity, and the threat of delisting.

SXT China (SXTC): Share Book Value from 07/04/2022 to 10/28/2026
Manufactured products of SXT China

This indicator determines the actual liquidation value of a single share package by subtracting total liabilities from the company's total assets. By analyzing the book value per share metric for China SXT Pharmaceuticals (SXTC), an investor can see the business foundation, the stability of which is constrained by low margins and a dependence on the cost of plant-based raw materials within a mature market.

Competitors of China SXT Pharmaceuticals (SXTC)

Accounting Value per Share Haleon Group HLN|KVUE - Book Price of a Share|VRNA (Verona Pharma plc) - Book Value per Share|MENS (jyongbio.com) - Accounting Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Quantum BioPharma - Book Value per Share|Accounting Value per Share FibroGen Inc FGEN|Book Value per Share Telomir Pharma (TELO)|RANI - Accounting Value of a Share|synergychc.com - Book Value per Share|RLYB (Rallybio) - Net Assets per Share|Net Assets per Single Share Lexaria Bioscience Corp (LEXX)|Equity per Share Pulmatrix Inc|Book Value per Share PTHL|Book Value per Share aptorumgroup.com APM|Accounting Value per Share Lyra Therapeutics, Inc.|Impact BioMedical, Inc. - Accounting Value of a Share|Net Assets per Single Share TNFA (TNF Pharma)|cbdMD, Inc. (YCBD) - Net Assets per Share|Accounting Value per Share PainReform Limited|Equity per Share Altamira Therapeutics Ltd.|Lipella Pharmaceuticals (LIPO) - Accounting Value per Share|Book Price of a Share optinose.com (OPTN)|Pieris Pharmaceuticals, Inc. (PIRS) - Accounting Value per Share|Accounting Value of a Share PROC (Procaps Group)|Petros (PTPI) - Net Assets per Single Share|Share Book Value Qilian International Corp QLI|Book Value per Share Acelyrin, Inc. (SLRN)|TFFP - Accounting Value of a Share